Aptar Pharma India Private Limited, a active private limited company, was established on 05 July 1999 in Kalyan, Maharashtra, India. Engaging in bottle & cap manufacturing within the manufacturing sector, it holds CIN: U29195MH1999PTC207807. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.80 Cr and a paid-up capital of ₹7.44 M.
Formerly known as Valois India Private Limited. It upholds a compliant status. Employing 320 professional, Its leadership includes Sanjay Digambar Kapote (Director), Anand Nanjayya Hiremath (Director), Gael Philippe Dominique Touya (Director). Past directors included Marc Andre Rene Jacques Prieur, Jean Marc Pardonge, Stephen Joseph Hagge. Its latest AGM occurred on 20 September 2024, with the balance sheet filed on 31 March 2024. It is based at A1, Survey No. 120/3/A And B, 120/4, 120/7, 120/10/B, Lodha Industrial And Logistics Park, Usatane, Ambarnath, Thane, Kalyan, Maharashtra, 421306.
U29195MH1999PTC207807
207807
05 July 1999
₹7.80 Cr
₹7.44 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Aptar Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Digambar Kapote | Director | 13 Mar 2023 | Current |
| Anand Nanjayya Hiremath | Director | 28 Jun 2022 | Current |
| Gael Philippe Dominique Touya | Director | 11 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Sep 2011 | Past |
| Pramod Abcsdd | Director | 13 Mar 2023 | Past |
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Director | 30 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 10 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aptar Pharma India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.35% increase. The company also saw a substantial improvement in profitability, with a 19.4% increase in profit. The company's net worth Soared by an impressive increase of 18.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aptar Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aptar Pharma India has a workforce of 320 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aptar Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aptar Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aptar Pharma India Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records. was completed.
Aptar Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Sanjay Digambar Kapote was appointed as a Director was appointed as a Director on 13 Mar 2023 & has been associated with this company since 2 years 8 months . was documented.
Anand Nanjayya Hiremath was appointed as a Director was appointed as a Director on 28 Jun 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
The activity Gael Philippe Dominique Touya was appointed as a Director was appointed as a Director on 11 Feb 2019 & has been associated with this company since 6 years 9 months . was completed.
The activity Aptar Pharma India Private Limited was registered on 05 Jul 1999 with Roc Mumbai & aged 26 years 4 months as per MCA records. was completed.
The CIN of Aptar Pharma India Private Limited is U29195MH1999PTC207807.
Aptar Pharma India Private Limited is headquartered at A1, Survey No. 120/3/A And B, 120/4, 120/7, 120/10/B, Lodha Industrial And Logistics Park, Usatane, Ambarnath, Thane, Kalyan, Maharashtra, 421306.
Aptar Pharma India Private Limited was incorporated on 05 July 1999.
The current directors of Aptar Pharma India Private Limited are
The primary industry of Aptar Pharma India Private Limited is Manufacturing.
Aptar Pharma India Private Limited is unlisted.
The authorized capital of Aptar Pharma India Private Limited is ₹7.80 Cr, and the paid-up capital is ₹7.44 M.
The compliance status of Aptar Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX